Clinical Trial Update: Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated intralesional bevacizumab for AIDS-associated Kaposi's sarcoma of the larynx, pharynx, and oral cavity, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Centro de Investigación en. Enfermedades Infecciosas, Mexico | Conditions: Kaposi´s Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2015-07-27